Congress·In Progress·H.R. 7877
Shane DiGiovanna Act
Medicaid Coverage for Rare Skin Disease Wound Care
Legislative Progress
House
Key Points
- This bill creates a two-year test program to require Medicaid to pay for wound care for people with a rare skin condition called epidermolysis bullosa. This condition makes skin extremely fragile, causing it to blister and tear from even the slightest touch.
- The program would cover the cost of essential supplies like specialized bandages, gauze, and antibiotic ointments. It also includes over-the-counter medicines like pain relievers and antihistamines that help patients manage constant pain and itching.
- This test would happen across the entire country to see if providing these supplies helps patients stay out of the hospital. After the two-year period, the government will study if the program improved health and if it saved money by preventing serious infections.
Impact Analysis
Govbase has not yet run an impact analysis on this legislation.
Milestones
2 milestones3 actions
Mar 17, 2026
Sponsor introductory remarks on measure. (CR H2535)
Mar 9, 2026
Referred to the House Committee on Energy and Commerce.
Mar 9, 2026
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
News
No related news coverage found for this legislation yet.
Source Information
Document Type
Congressional Bill
Official Title
Shane DiGiovanna Act
Bill NumberHR 7877
Congress119th Congress
ChamberHouse of Representatives
Latest ActionSponsor introductory remarks on measure. (CR H2535)
Data Sources
Sponsor
Cosponsors
(4)D: 4
Analysis generated by AI. Always verify with official sources.